{'output': [['Retrophin, Inc.', 'COMP', 'Announce', 'Net Product Sales', 'ECON_INDICATOR'], ['Retrophin, Inc.', 'COMP', 'Expect', 'Total Net Product Sales', 'ECON_INDICATOR'], ['Retrophin, Inc.', 'COMP', 'Participates_In', 'Development Programs', 'CONCEPT'], ['Retrophin, Inc.', 'COMP', 'Anticipate', 'Milestones', 'CONCEPT'], ['Retrophin, Inc.', 'COMP', 'Operate_In', 'Rare Diseases Sector', 'SECTOR'], ['Fosmetpantotenate', 'PRODUCT', 'Continue', 'Enroll', 'Patients'], ['Fosmetpantotenate', 'PRODUCT', 'Complete', 'Enrollment', 'CONCEPT'], ['Sparsentan', 'PRODUCT', 'Support', 'Phase 3 Trial Design', 'CONCEPT'], ['Sparsentan', 'PRODUCT', 'Eligibility', 'Subpart H Accelerated Approval Pathway', 'CONCEPT'], ['Sparsentan', 'PRODUCT', 'Resubmit', 'Phase 3 Protocol', 'CONCEPT'], ['CNSA-001', 'PRODUCT', 'Begin', 'Clinical Development', 'CONCEPT'], ['CNSA-001', 'PRODUCT', 'Phase 2 Proof-of-Concept Study', 'Results', 'CONCEPT'], ['Retrophin, Inc.', 'COMP', 'Expect', 'New Drug Application Filing', 'CONCEPT'], ['Retrophin, Inc.', 'COMP', 'Anticipate', 'Marketing Efforts', 'CONCEPT'], ['Retrophin, Inc.', 'COMP', 'Announce', 'Final Financial Results', 'CONCEPT'], ['Retrophin, Inc.', 'COMP', 'Provide', 'Detailed Corporate Update', 'CONCEPT']]}